Patents by Inventor Bertil Wachall

Bertil Wachall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of potassium hydroxide in the treatment of actinic keratosis
    Patent number: 11045494
    Abstract: An agent in the form of potassium hydroxide (KOH) in a pharmaceutically acceptable composition is used in the dermal treatment of actinic keratosis. The composition may be an aqueous alkaline solution of potassium hydroxide and topically applied to the skin or on the scalp, within the face, the neck, the nose, as well as on the bosom.
    Type: Grant
    Filed: July 10, 2015
    Date of Patent: June 29, 2021
    Assignee: Infectopharm Arzneimittel und Consilium GmbH
    Inventors: Thomas Wimmer, Bertil Wachall, Philip Zoeller, Alessandro Giunta
  • USE OF POTASSIUM HYDROXIDE IN THE TREATMENT OF ACTINIC KERATOSIS
    Publication number: 20180185409
    Abstract: An agent in the form of potassium hydroxide (KOH) in a pharmaceutically acceptable composition is used in the dermal treatment of actinic keratosis. The composition may be an aqueous alkaline solution of potassium hydroxide and topically applied to the skin or on the scalp, within the face, the neck, the nose, as well as on the bosom.
    Type: Application
    Filed: July 10, 2015
    Publication date: July 5, 2018
    Applicant: Infectopharm Arzneimittel und Consilium GmbH
    Inventors: Thomas WIMMER, Bertil WACHALL, Philip ZOELLER, Alessandro GIUNTA
  • Dihydronaphthalene compounds
    Patent number: 6559157
    Abstract: Dihydronaphthalene compounds have excellent 17&agr;-hydroxylase/C17-20-lyase inhibiting activity, thromboxan A2 synthesis inhibiting activity, and aromatase inhibiting activity and are thereby are useful as preventive and/or therapeutic agents for various male sex hormone- and female sex hormone-dependent diseases such as prostate cancer, prostatomegaly, masculinization, breast cancer, mastopathy, uterine cancer, endometriosis, and ovarian cancer, as well as myocardial infarction, angina pectoris, and bronchial asthma.
    Type: Grant
    Filed: May 25, 2001
    Date of Patent: May 6, 2003
    Assignee: Daiichi Pharmaceutical Co., Ltd.
    Inventors: Rolf Wolfgang Hartmann, Bertil Wachall, Makoto Yoshihama, Masamichi Nakakoshi, Shin Nomoto, Yoshikazu Ikeda
  • Novel dihydronaphthalene compounds and processes of producing the same
    Publication number: 20020032211
    Abstract: Dihydronaphthalene compounds have excellent 17&agr;-hydroxylase/C17-20-lyase inhibiting activity, thromboxan A2 synthesis inhibiting activity, and aromatase inhibiting activity and are thereby are useful as preventive and/or therapeutic agents for various male sex hormone- and female sex hormone-dependent diseases such as prostate cancer, prostatomegaly, masculinization, breast cancer, mastopathy, uterine cancer, endometriosis, and ovarian cancer, as well as myocardial infarction, angina pectoris, and bronchial asthma.
    Type: Application
    Filed: May 25, 2001
    Publication date: March 14, 2002
    Inventors: Rolf Wolfgang Hartmann, Bertil Wachall, Makoto Yoshihama, Masamichi Nakakoshi, Shin Nomoto, Yoshikazu Ikeda